New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
- PMID: 28574057
- DOI: 10.1038/cgt.2017.16
New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles
Abstract
Cancer is one of the leading cause of death in the world with the prevalence of >10 million mortalities annually. Current cancer treatments include surgical intervention, radiation, and taking chemotherapeutic drugs, which often kill the healthy cells and result in toxicity in patients. Therefore, researchers are looking for ways to be able to eliminate just cancerous cells. Intra-tumor heterogeneity of cancerous cells is the main obstacle on the way of an effective cancer treatment. However, better comprehension of molecular basis of tumor and the advent of new diagnostic technologies can help to improve the treatment of various cancers. Therefore, study of epigenetic changes, gene expression of cancerous cells and employing methods that enable us to correct or minimize these changes is critically important. In this paper, we will review the recent advanced strategies being used in the field of cancer research.
Similar articles
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Nano cancer therapy strategies.J Cancer Res Ther. 2012 Jan-Mar;8(1):19-22. doi: 10.4103/0973-1482.95168. J Cancer Res Ther. 2012. PMID: 22531508 Review.
-
Nanoparticle-siRNA: A potential cancer therapy?Crit Rev Oncol Hematol. 2016 Feb;98:159-69. doi: 10.1016/j.critrevonc.2015.10.015. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26597018 Review.
-
Advances in targeting strategies for nanoparticles in cancer imaging and therapy.Nanoscale. 2014 Nov 21;6(22):13383-90. doi: 10.1039/c4nr04334k. Nanoscale. 2014. PMID: 25273283 Review.
-
New Frontiers in Promoting TRAIL-Mediated Cell Death: Focus on Natural Sensitizers, miRNAs, and Nanotechnological Advancements.Cell Biochem Biophys. 2016 Mar;74(1):3-10. doi: 10.1007/s12013-015-0712-7. Cell Biochem Biophys. 2016. PMID: 26972296 Review.
Cited by
-
Light-activated nanomaterials for tumor immunotherapy.Front Chem. 2022 Oct 7;10:1031811. doi: 10.3389/fchem.2022.1031811. eCollection 2022. Front Chem. 2022. PMID: 36277335 Free PMC article. Review.
-
Different origin-derived exosomes and their clinical advantages in cancer therapy.Front Immunol. 2024 Jun 27;15:1401852. doi: 10.3389/fimmu.2024.1401852. eCollection 2024. Front Immunol. 2024. PMID: 38994350 Free PMC article. Review.
-
Immunotherapy of targeting MDSCs in tumor microenvironment.Front Immunol. 2022 Sep 5;13:990463. doi: 10.3389/fimmu.2022.990463. eCollection 2022. Front Immunol. 2022. PMID: 36131911 Free PMC article. Review.
-
Bacteria-mediated tumor immunotherapy via photothermally-programmed PD1 expression.Nanoscale Adv. 2022 Feb 7;4(6):1577-1586. doi: 10.1039/d1na00857a. eCollection 2022 Mar 15. Nanoscale Adv. 2022. PMID: 36134371 Free PMC article.
-
Decoding the multidimensional signatures of resident and expanded natural killer cells generated from perinatal blood.Am J Cancer Res. 2022 May 15;12(5):2132-2145. eCollection 2022. Am J Cancer Res. 2022. PMID: 35693070 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical